Korea Joongang Daily
Korea JoongAng Daily

LG's autoimmune drug candidate wins Phase 2 clinical trial approval in China

LG Chem's LC510255 autoimmune disease drug candidate won approval to start Phase 2 clinical trials in China as an atopy treatment, the Korean chemical company said Wednesday.

2022-04-20

JW Pharmaceutical's JW1601 begins Phase 2 clinical trials

JW1601, an oral atopy treatment candidate that was licensed by JW Pharmaceutical to Ballerup, Denmark-based Leo Pharma began Phase 2 clinical trials, the Korean company said Wednesday.

2021-12-15